All Stories

  1. PCSK9 Inhibition-Based Therapeutic Approaches: An Immunotherapy Perspective

    Article • Current Medicinal Chemistry, February 2022, Bentham Science Publishers

    Dr Suowen Xu

  2. New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds_

    Article • Current Medicinal Chemistry, November 2020, Bentham Science Publishers

    Professor Luciano Saso, Prof. Maciej Banach, Ana Sanches Silva, Dr Suowen Xu, Dr Seyed Mohammad Nabavi, Prof. Antoni Sureda

  3. Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling

    Article • Translational Research, March 2015, Elsevier

    Dr Suowen Xu

  4. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E‐deficient mice: role of lectin‐like oxidized LDL receptor‐1 (LOX‐1)

    Article • British Journal of Pharmacology, February 2015, Wiley

    Dr Suowen Xu

  5. Essential roles of Gab1 tyrosine phosphorylation in growth factor-mediated signaling and angiogenesis

    Article • International Journal of Cardiology, February 2015, Elsevier

    Dr Suowen Xu

  6. Osthole, a Natural Coumarin Improves Cognitive Impairments and BBB Dysfunction After Transient Global Brain Ischemia in C57 BL/6J Mice: Involvement of Nrf2 Pathway

    Article • Neurochemical Research, November 2014, Springer Science + Business Media

    Dr Suowen Xu

  7. Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling

    Article • Archives of Biochemistry and Biophysics, November 2014, Elsevier

    Dr Suowen Xu

  8. Cryptotanshinone Attenuates Cardiac Fibrosis via Downregulation of COX-2, NOX-2, and NOX-4

    Article • Journal of Cardiovascular Pharmacology, July 2014, Wolters Kluwer Health

    Dr Suowen Xu

  9. Effectiveness of combination therapy of atorvastatin and non lipid-modifying tanshinone IIA from Danshen in a mouse model of atherosclerosis

    Article • International Journal of Cardiology, July 2014, Elsevier

    Dr Suowen Xu

  10. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis

    Article • International Journal of Cardiology, March 2014, Elsevier

    Dr Suowen Xu

  11. Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis

    Article • CHEST Journal, January 2014, Elsevier

    Dr Suowen Xu

  12. Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation

    Article • Cellular Signalling, October 2013, Elsevier

    Dr Suowen Xu, Danielle Kamato

  13. HDL cholesterol in cardiovascular diseases: The good, the bad, and the ugly?

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr Suowen Xu

  14. Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

    Article • Medicinal Research Reviews, September 2013, Wiley

    Dr Suowen Xu

  15. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4

    Article • Molecular and Cellular Endocrinology, May 2013, Elsevier

    Dr Suowen Xu

  16. Rock the Rock of Atherosclerosis

    Article • Journal of Vascular Medicine & Surgery, January 2013, OMICS Publishing Group

    Dr Suowen Xu

  17. Tanshinone II-A: new perspectives for old remedies

    Article • Expert Opinion on Therapeutic Patents, December 2012, Informa Healthcare

    Dr Suowen Xu

  18. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

    Article • Cellular and Molecular Life Sciences, November 2012, Springer Science + Business Media

    Dr Suowen Xu

  19. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes

    Article • Molecular and Cellular Endocrinology, October 2012, Elsevier

    Dr Suowen Xu

  20. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation

    Article • Translational Research, August 2012, Elsevier

    Dr Suowen Xu

  21. Corrigendum to: Cardiovascular actions and therapeutic potential of tanshinone IIA [Atherosclerosis 220 (2012) 3–10]

    Article • Atherosclerosis, April 2012, Elsevier

    Dr Suowen Xu

  22. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4

    Article • Archives of Biochemistry and Biophysics, February 2012, Elsevier

    Dr Suowen Xu

  23. Cardiovascular actions and therapeutic potential of tanshinone IIA

    Article • Atherosclerosis, January 2012, Elsevier

    Dr Suowen Xu

  24. Sphingosine Kinase-1 Pathway Mediates High Glucose-Induced Fibronectin Expression in Glomerular Mesangial Cells

    Article • Molecular Endocrinology, December 2011, Endocrine Society

    Dr Suowen Xu

  25. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet

    Article • Archives of Biochemistry and Biophysics, November 2011, Elsevier

    Dr Suowen Xu

  26. Osthole, a natural coumarin, improves neurobehavioral functions and reduces infarct volume and matrix metalloproteinase-9 activity after transient focal cerebral ischemia in rats

    Article • Brain Research, April 2011, Elsevier

    Dr Suowen Xu

  27. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography–tandem mass spectrometry

    Article • Journal of Chromatography B, March 2011, Elsevier

    Dr Suowen Xu

  28. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway

    Article • Molecular and Cellular Endocrinology, January 2011, Elsevier

    Dr Suowen Xu

  29. Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake

    Article • Cytotechnology, October 2010, Springer Science + Business Media

    Dr Suowen Xu

  30. RETRACTED: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway

    Article • Archives of Biochemistry and Biophysics, October 2010, Elsevier

    Dr Suowen Xu

  31. Determination of sphingosine kinase activity in biological samples by liquid chromatography–tandem mass spectrometry

    Article • Biomedical Chromatography, September 2010, Wiley

    Dr Suowen Xu

  32. Regulated expression of endothelial lipase in atherosclerosis

    Article • Molecular and Cellular Endocrinology, February 2010, Elsevier

    Dr Suowen Xu

  33. Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas

    Article • Cytotechnology, November 2009, Springer Science + Business Media

    Dr Suowen Xu